Healthcare Delivery

Dr Jill Jarecki Discusses Whether Gender Affects SMA Severity

October 31st 2020, 11:00am


Jill Jarecki, PhD, chief scientific officer at Cure SMA explained the current data and potential for gender to impact the severity spinal muscular atrophy (SMA).

Dr Milena Murray on the Importance of Using People-First Language With Patients Living With HIV

October 30th 2020, 6:00pm


The patients must always come first, emphasized Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor at Midwestern University College of Pharmacy, who practices at the Northwestern Medicine Infectious Disease Center in Chicago.

Research Highlights Impact of SDOH on Veterans With CKD

October 30th 2020, 4:00pm


A pair of abstracts presented at Kidney Week 2020 underscore the relationship between social determinants of health (SDOH) and chronic kidney disease (CKD) in military populations and the challenges of tracking these factors.

Foundation Medicine Notches Additional FDA Approvals

October 29th 2020, 11:30pm


The FDA has approved new indications for Foundation Medicine's liquid biopsy assay and also its tissue-based companion diagnostic for solid tumors.

Contributor: Telehealth Shows Staying Power During COVID-19 Pandemic

October 29th 2020, 8:30pm


Robin Gelburd, JD, president of FAIR Health, discusses consistent telehealth use throughout the coronavirus disease 2019 (COVID-19) pandemic.

HHS Wraps Up Rule Requiring Price Transparency by Payers

October 29th 2020, 3:05pm


The Trump administration finalized rules aimed at making health care pricing more visible and transparent to those with with health insurance from employers or the individual market.

Panelists Discuss Community-Based Approaches to Mitigate Costs, Improve SDOH Outcomes

October 28th 2020, 7:39pm


At the Alliance for Better Health’s CONVERGE Virtual Conference, experts discussed the role social determinants of health (SDOH) play in community-based health initiatives.

Weighing the Pros, Cons of At-Home Use of Biologics for Asthma

October 28th 2020, 7:30pm


When the first biologic to treat asthma was approved by the FDA in 2003, it needed to be administered subcutaneously in the physician’s office. Now, there are 3 options available for at-home use: mepolizumab, benralizumab, and dupilumab.

Sacubitril/Valsartan Treatment for HFrEF Results in Removal of Prior Authorization Requirement

October 28th 2020, 4:42pm


Study results demonstrate the multimillion-dollar savings achieved among patients with heart failure with reduced ejection fraction (HFrEF) following treatment initiation with sacubitril and valsartan.

Keeping Physicians Independent: Dr Patricia Salber Interviews Dr Farzad Mostashari

October 27th 2020, 6:30pm


Patricia Salber, MD, MBA, of The Doctor Weighs in, speaks with Aledade co-founder, Farzad Mostashari, MD, about how his company is keeping physicians independent through value-based care.